Incidence, risk factors and impact of seasonal influenza in pregnancy: A national cohort study
Background
Pregnant women are particularly vulnerable to severe infection from influenza resulting in poor neonatal outcomes. The majority of evidence relates to pandemic 2009 A/H1N1 influenza. The objective of this study was to describe the characteristics and outcomes of pregnant women hospitalised with seasonal influenza.
Methods
This national, prospective, observational cohort study used the UK Obstetric Surveillance System (UKOSS) to identify all pregnant women admitted to hospital between 01/11/2016 and 31/10/2018 with laboratory confirmed influenza at any gestation and up to two days after giving birth. These were compared to women admitted to give birth that did not have influenza. Baseline characteristics, immunization status, maternal and perinatal outcomes were compared.
Results
There were 405 women admitted to hospital with laboratory confirmed influenza in pregnancy: 2.7 per 10,000 maternities. Compared to 694 comparison women, women with influenza were less likely to be professionally employed (aOR 0.59, 95%CI 0.39–0.89) or immunised in the relevant season (aOR 0·59, 0·39–0·89) and more likely to have asthma (aOR 2.42, 1.30–4.49) or have had a previous pregnancy complication (aOR 2·47, 1·33–4·61). They were more likely to be admitted to intensive care (aOR 21.3, 2.78–163.1) and to have a cesarean birth (aOR 1·42, 1·02–1.98). Their babies were more likely to be admitted to neonatal intensive care (aOR 1.86, 1·01–3·42).
Conclusions
Immunization reduces the risk of hospitalisation with influenza in pregnancy which is associated with increased risk of morbidity for both the mother and baby. There is a continued need to increase awareness of safety and effectiveness of immunization in pregnancy and provision within antenatal care settings, especially for high-risk groups.
Top-30
Journals
|
1
2
3
|
|
|
Vaccine
3 publications, 9.68%
|
|
|
Human Vaccines and Immunotherapeutics
2 publications, 6.45%
|
|
|
Frontiers in Immunology
1 publication, 3.23%
|
|
|
Viruses
1 publication, 3.23%
|
|
|
BMC Infectious Diseases
1 publication, 3.23%
|
|
|
American Journal of Obstetrics and Gynecology
1 publication, 3.23%
|
|
|
Heliyon
1 publication, 3.23%
|
|
|
Biochimica et Biophysica Acta - Molecular Basis of Disease
1 publication, 3.23%
|
|
|
The Obstetrician & Gynaecologist
1 publication, 3.23%
|
|
|
Ultrasound in Obstetrics and Gynecology
1 publication, 3.23%
|
|
|
BMJ Open
1 publication, 3.23%
|
|
|
European Journal of Neurology
1 publication, 3.23%
|
|
|
Multiple Sclerosis Journal
1 publication, 3.23%
|
|
|
bioRxiv
1 publication, 3.23%
|
|
|
BMC Pregnancy and Childbirth
1 publication, 3.23%
|
|
|
Current Topics in Microbiology and Immunology
1 publication, 3.23%
|
|
|
mBio
1 publication, 3.23%
|
|
|
Clinical Microbiology Reviews
1 publication, 3.23%
|
|
|
Reproductive Medicine
1 publication, 3.23%
|
|
|
BJOG: An International Journal of Obstetrics and Gynaecology
1 publication, 3.23%
|
|
|
PLoS ONE
1 publication, 3.23%
|
|
|
Vaccines
1 publication, 3.23%
|
|
|
Journal of Reproductive Immunology
1 publication, 3.23%
|
|
|
Pediatric Infectious Disease Journal
1 publication, 3.23%
|
|
|
Nature Reviews Immunology
1 publication, 3.23%
|
|
|
Health Education Journal
1 publication, 3.23%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 25.81%
|
|
|
Springer Nature
4 publications, 12.9%
|
|
|
Wiley
4 publications, 12.9%
|
|
|
MDPI
3 publications, 9.68%
|
|
|
Taylor & Francis
2 publications, 6.45%
|
|
|
SAGE
2 publications, 6.45%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 6.45%
|
|
|
American Society for Microbiology
2 publications, 6.45%
|
|
|
Frontiers Media S.A.
1 publication, 3.23%
|
|
|
BMJ
1 publication, 3.23%
|
|
|
Public Library of Science (PLoS)
1 publication, 3.23%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 3.23%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.